-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades HOOKIPA Pharma to Neutral

Benzinga·01/10/2025 12:27:07
Listen to the news
HC Wainwright & Co. analyst Arthur He downgrades HOOKIPA Pharma (NASDAQ:HOOK) from Buy to Neutral.